United States · FDA National Drug Code directory
ELAPRASE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54092-700_25f45811-e646-4342-9954-d8220cadf886
- Product NDC
- 54092-700
- Form
- SOLUTION, CONCENTRATE
- Composition / generic term
- idursulfase
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20060724
- Source listing expiry
- 20261231
Source-listed ingredients
- IDURSULFASE — 6 mg/3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 BOX (54092-700-01) / 3 mL in 1 VIAL, GLASS · 54092-700-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →